WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report)’s share price rose 16.3% on Thursday. The company traded as high as $25.9070 and last traded at $25.9070. 929 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 5,283 shares. The stock had previously closed at $22.28.
Analyst Upgrades and Downgrades
Separately, Zacks Research upgraded WuXi AppTec from a “hold” rating to a “strong-buy” rating in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Strong Buy”.
Check Out Our Latest Research Report on WUXAY
WuXi AppTec Price Performance
The company’s 50-day moving average is $25.41 and its 200 day moving average is $19.36.
WuXi AppTec Company Profile
WuXi AppTec is a global pharmaceutical and biotechnology services company that provides contract research, development and manufacturing services. The company supports drug developers throughout the product life cycle, from early-stage discovery and laboratory testing through clinical development and commercial production.
Its offerings include medicinal and synthetic chemistry, biology research, preclinical and clinical testing, regulatory support, pharmaceutical manufacturing, and the development and manufacturing of advanced therapies.
See Also
- Five stocks we like better than WuXi AppTec
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
- South Korea’s Chip Exports Are Soaring—So Why Is This ETF Down 20%?
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
